Century Therapeutics, Inc. SEC filings IPSC
Century Therapeutics, Inc. has 444 filings in SEC EDGAR's recent list, going back to Mar 15, 2021. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 2, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 2, 2026 | Oct 2, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 9, 2026 | Sep 9, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 12, 2026 | Aug 12, 2026 |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 16, 2026 | Jun 15, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 12, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Other events
|
Jun 8, 2026 | Jun 8, 2026 |
| 424B7 | Filing | May 21, 2026 | — |
| 8-K |
Current report
Results of operations
|
May 13, 2026 | May 13, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| DEFA14A | Additional proxy material | Apr 27, 2026 | — |
| DEF 14A | Proxy statement | Apr 27, 2026 | Jun 11, 2026 |
| ARS | Annual report to shareholders | Apr 16, 2026 | Dec 31, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 16, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Other events
|
Mar 26, 2026 | Mar 26, 2026 |
| 424B5 | Prospectus supplement | Mar 26, 2026 | — |
| S-8 | Employee stock plan registration | Mar 12, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 12, 2026 | Mar 12, 2026 |
| 10-K | Annual report | Mar 12, 2026 | Dec 31, 2025 |
| EFFECT | Filing | Feb 17, 2026 | — |
| UPLOAD | Letter from the SEC | Feb 17, 2026 | — |
| CORRESP | Letter to the SEC | Feb 17, 2026 | — |
| S-3 | Shelf registration | Feb 5, 2026 | — |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jan 23, 2026 | Jan 22, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| EFFECT | Filing | Jan 9, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jan 8, 2026 | Jan 7, 2026 |
| CORRESP | Letter to the SEC | Jan 7, 2026 | — |
| S-3/A | Filing | Jan 5, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Dec 29, 2025 | Dec 18, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 12, 2025 | Dec 12, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 9, 2025 | Dec 9, 2025 |
| DEFA14A | Additional proxy material | Dec 2, 2025 | — |
| DEF 14A | Proxy statement | Dec 2, 2025 | Jan 22, 2026 |
| PRE 14A | Preliminary proxy statement | Nov 21, 2025 | Jan 22, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Nov 13, 2025 | Nov 13, 2025 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Listing notice
|
Aug 29, 2025 | Aug 27, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Aug 14, 2025 | Aug 13, 2025 |
| UPLOAD | Letter from the SEC | Jul 14, 2025 | — |
| S-3 | Shelf registration | Jul 10, 2025 | — |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change
|
Jul 7, 2025 | Jul 1, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2025 | Jun 12, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 15, 2025 | May 15, 2025 |
| ARS | Annual report to shareholders | Apr 22, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 22, 2025 | — |
| DEF 14A | Proxy statement | Apr 22, 2025 | Jun 12, 2025 |
| S-8 | Employee stock plan registration | Mar 20, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 19, 2025 | Mar 19, 2025 |
| 10-K | Annual report | Mar 19, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Listing notice
|
Feb 28, 2025 | Feb 26, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Agreement ended
|
Dec 13, 2024 | Dec 12, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 5, 2024 | Nov 5, 2024 |
| 10-Q | Quarterly report | Nov 5, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 26, 2024 | Sep 26, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 8, 2024 | Aug 8, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Other events
|
Jul 8, 2024 | Jul 8, 2024 |
| EFFECT | Filing | Jun 26, 2024 | — |
| 8-K/A | Amended current report | Jun 26, 2024 | Apr 11, 2024 |
| 424B3 | Prospectus | Jun 26, 2024 | — |
| CORRESP | Letter to the SEC | Jun 25, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 24, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 24, 2024 | Jun 20, 2024 |
| S-3 | Shelf registration | Jun 18, 2024 | — |
| 8-K |
Current report
Other events
|
Jun 3, 2024 | Jun 3, 2024 |
| 424B3 | Prospectus | May 22, 2024 | — |
| EFFECT | Filing | May 21, 2024 | — |
| CORRESP | Letter to the SEC | May 17, 2024 | — |
| UPLOAD | Letter from the SEC | May 17, 2024 | — |
| S-3 | Shelf registration | May 15, 2024 | — |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 20, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 16, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Acquisition or sale of assets, Unregistered share sale, Regulation FD disclosure
|
Apr 11, 2024 | Apr 11, 2024 |
| 8-K |
Current report
Other events
|
Apr 11, 2024 | Apr 11, 2024 |
| 8-K |
Current report
Other events
|
Apr 9, 2024 | Apr 8, 2024 |
| S-8 | Employee stock plan registration | Mar 14, 2024 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 14, 2024 | Mar 14, 2024 |
| 10-K | Annual report | Mar 14, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Officer or director change
|
Jan 19, 2024 | Jan 15, 2024 |
| 8-K |
Current report
Other events
|
Dec 11, 2023 | Dec 9, 2023 |
| 8-K |
Current report
Other events
|
Dec 6, 2023 | Dec 6, 2023 |
| 8-K |
Current report
Officer or director change
|
Nov 14, 2023 | Nov 7, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 9, 2023 | Nov 9, 2023 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Other events
|
Oct 3, 2023 | Oct 3, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 9, 2023 | Aug 9, 2023 |
| 10-Q | Quarterly report | Aug 9, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 29, 2023 | Jun 27, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| 8-K/A |
Amended current report
Officer or director change
|
May 5, 2023 | Apr 11, 2023 |
| 8-K |
Current report
Agreement ended
|
May 5, 2023 | May 1, 2023 |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 27, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 17, 2023 | Apr 11, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 20, 2023 | Mar 20, 2023 |
| S-8 | Employee stock plan registration | Mar 17, 2023 | — |
| 8-K |
Current report
Results of operations
|
Mar 16, 2023 | Mar 16, 2023 |
| 10-K | Annual report | Mar 16, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 13, 2023 | Mar 13, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 9, 2023 | Jan 5, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 30, 2022 | Nov 30, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Officer or director change
|
Oct 3, 2022 | Sep 28, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 8, 2022 | Sep 8, 2022 |
| 8-K |
Current report
Other events
|
Aug 25, 2022 | Aug 25, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2022 | Aug 11, 2022 |
| 10-Q | Quarterly report | Aug 11, 2022 | Jun 30, 2022 |
| EFFECT | Filing | Jul 13, 2022 | — |
| CORRESP | Letter to the SEC | Jul 11, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 8, 2022 | — |
| 8-K |
Current report
Material agreement
|
Jul 1, 2022 | Jul 1, 2022 |
| S-3 | Shelf registration | Jul 1, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 13, 2022 | Jun 13, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2022 | Jun 9, 2022 |
| 10-Q | Quarterly report | May 16, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 16, 2022 | May 16, 2022 |
| 8-K |
Current report
Other events
|
May 10, 2022 | May 10, 2022 |
| DEFA14A | Additional proxy material | Apr 21, 2022 | — |
| DEF 14A | Proxy statement | Apr 21, 2022 | Jun 9, 2022 |
| 8-K |
Current report
Other events
|
Apr 13, 2022 | Apr 13, 2022 |
| S-8 | Employee stock plan registration | Mar 17, 2022 | — |
| 10-K | Annual report | Mar 17, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 17, 2022 | Mar 17, 2022 |
| 8-K |
Current report
Material agreement
|
Jan 13, 2022 | Jan 7, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 11, 2022 | Jan 11, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jan 10, 2022 | Jan 7, 2022 |
| 8-K |
Current report
Other events
|
Dec 16, 2021 | Dec 16, 2021 |
| 8-K |
Current report
Other events
|
Nov 18, 2021 | Nov 18, 2021 |
| 10-Q | Quarterly report | Nov 10, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2021 | Nov 10, 2021 |
| 8-K |
Current report
Other events
|
Oct 13, 2021 | Oct 13, 2021 |
| 10-Q | Quarterly report | Aug 12, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 12, 2021 | Aug 12, 2021 |
| S-8 | Employee stock plan registration | Jul 2, 2021 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jun 25, 2021 | Jun 22, 2021 |
| 424B4 | Prospectus | Jun 21, 2021 | — |
| EFFECT | Filing | Jun 17, 2021 | — |
| SEC STAFF LETTER | Filing | Jun 17, 2021 | — |
| CERT | Withdrawing incorrect 8a cert, accession number: 0001354457-21-000666 | Jun 17, 2021 | — |
| CERT | Filing | Jun 16, 2021 | — |
| CERT | Filing | Jun 16, 2021 | — |
| CORRESP | Letter to the SEC | Jun 15, 2021 | — |
| CORRESP | Letter to the SEC | Jun 15, 2021 | — |
| S-1/A | Amended registration statement | Jun 15, 2021 | — |
| 8-A12B | Filing | Jun 14, 2021 | — |
| S-1/A | Amended registration statement | Jun 14, 2021 | — |
| CORRESP | Letter to the SEC | Jun 10, 2021 | — |
| SEC STAFF LETTER | Filing | Jun 7, 2021 | — |
| CORRESP | Letter to the SEC | May 28, 2021 | — |
| S-1 | Registration statement | May 28, 2021 | — |
| UPLOAD | Letter from the SEC | May 21, 2021 | — |
| SEC STAFF LETTER | Filing | May 18, 2021 | — |
| DRSLTR | Filing | May 5, 2021 | — |
| DRS/A | Filing | May 5, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 23, 2021 | — |
| DRS | Filing | Mar 26, 2021 | — |
| D | Filing | Mar 15, 2021 | — |
Showing 169 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- IPSC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Philadelphia, PA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1850119
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.